CSL's R&D chief says the company's new hereditary angioedema treatment is one of only a few drugs to be built from scratch in ...

If Island Pharma’s drug keeps delivering, it could fast-track approval. And in a world with millions of dengue cases a year, ...

LinQ Minerals is breaking the drought for gold IPOs on the ASX, raising $10m to explore and develop the 3.7Moz Gilmore ...

Besra Gold (ASX:BEZ) continues to de-risk key workstreams required to complete the bankable feasibility study for its Jugan ...

Canaccord Genuity has initiated on WA gold developer Ausgold with a $1.60 price target, more than double is current price ahead of a DFS.

Good morning! Here’s everything you need to know before the ASX flings open its doors and begins trading today.

Visible gold has been observed in the first drill hole of Olympio Metals’ maiden drilling program at the Bousquet gold ...

The idea that safety only comes in one shade – the green of the US dollar – is no longer credible, writes Nigel Green.

The ASX lifted 1pc as the Iran-Israel ceasefire loomed today. Materials and financials lead gains, while the energy sector ...

The RBA has been cutting rates. So have the banks. But which ones are offering the best deals? It might be time to shop ...

Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...

Nuclear momentum across Europe is putting Sweden's 2018 uranium mining ban back in the spotlight with Aura and Basin Energy ...